-
M.
Kuijjer,
Elisabeth
Peterse,
B.
Akker,
I.
Bruijn,
M.
Serra,
L.
Meza-Zepeda,
O.
Myklebost,
A
Hassan,
P.C.W
Hogendoorn,
A.
Cleton-Jansen
(2013)
IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma
BMC Cancer, 13
-
Yangyang
Wang,
Claudia
Geldres,
S.
Ferrone,
G.
Dotti
(2015)
Chondroitin sulfate proteoglycan 4 as a target for chimeric antigen receptor-based T-cell immunotherapy of solid tumors
Expert Opinion on Therapeutic Targets, 19
-
Pier
Nicolosi,
A.
Dallatomasina,
R.
Perris
(2015)
Theranostic Impact of NG2/CSPG4 Proteoglycan in Cancer
Theranostics, 5
-
R.
Beard,
D.
Abate-Daga,
Shannon
Rosati,
Zhili
Zheng,
J.
Wunderlich,
S.
Rosenberg,
R.
Morgan
(2013)
Gene Expression Profiling using Nanostring Digital RNA Counting to Identify Potential Target Antigens for Melanoma Immunotherapy
Clinical Cancer Research, 19
-
F.
Cavallo,
R.
Calogero,
G.
Forni
(2007)
Are oncoantigens suitable targets for anti-tumour therapy?
Nature Reviews Cancer, 7
-
A.
Goorin,
D.
Schwartzentruber,
M.
Devidas,
M.
Gebhardt,
A.
Ayala,
M.
Harris,
L.
Helman,
H.
Grier,
M.
Link
(2003)
Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 8
-
R.
Beard,
Zhili
Zheng,
Kiran
Lagisetty,
W.
Burns,
E.
Tran,
S.
Hewitt,
D.
Abate-Daga,
Shannon
Rosati,
H.
Fine,
S.
Ferrone,
S.
Rosenberg,
R.
Morgan
(2014)
Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells
Journal for Immunotherapy of Cancer, 2
-
M.
Price,
Leah
Wanshura,
Jianbo
Yang,
J.
Carlson,
Bo
Xiang,
Gui-yuan
Li,
S.
Ferrone,
A.
Dudek,
E.
Turley,
J.
McCarthy
(2011)
CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma
Pigment Cell & Melanoma Research, 24
-
M.
Ziai,
L.
Imberti,
M.
Nicotra,
G.
Badaracco,
O.
Segatto,
P.
Natali,
S.
Ferrone
(1987)
Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
Cancer research, 47 9
-
A.
Schmidt,
R.
Groenwold,
P.
Amsellem,
N.
Bacon,
O.
Klungel,
A.
Hoes,
A.
Boer,
K.
Kow,
K.
Maritato,
J.
Kirpensteijn,
M.
Nielen
(2016)
Which dogs with appendicular osteosarcoma benefit most from chemotherapy after surgery? Results from an individual patient data meta-analysis.
Preventive veterinary medicine, 125
-
Siobhan
Simpson,
M.
Dunning,
S.
Brot,
L.
Grau-Roma,
N.
Mongan,
Catrin
Rutland
(2017)
Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics
Acta Veterinaria Scandinavica, 59
-
Anja
Luetke,
P.
Meyers,
I.
Lewis,
H.
Juergens
(2014)
Osteosarcoma treatment - where do we stand? A state of the art review.
Cancer treatment reviews, 40 4
-
E.
Morello,
M.
Martano,
P.
Buracco
(2011)
Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma.
Veterinary journal, 189 3
-
M.
Ehnman,
O.
Larsson
(2015)
Microenvironmental Targets in Sarcoma
Frontiers in Oncology, 5
-
I.
Kozanoglu,
C.
Boğa,
H.
Ozdogu,
Oktay
Sozer,
E.
Maytalman,
A.
Yazici,
F.
Sahin
(2009)
Human bone marrow mesenchymal cells express NG2: possible increase in discriminative ability of flow cytometry during mesenchymal stromal cell identification.
Cytotherapy, 11 5
-
M.
Kuijjer,
H.
Rydbeck,
S.
Kresse,
E.
Buddingh,
Ana
Lid,
H.
Roelofs,
H.
Bürger,
O.
Myklebost,
P.
Hogendoorn,
L.
Meza-Zepeda,
A.
Cleton-Jansen
(2012)
Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data
Genes, 51
-
Elena
Garusi,
S.
Rossi,
R.
Perris
(2012)
Antithetic roles of proteoglycans in cancer
Cellular and Molecular Life Sciences, 69
-
D.
Virgintino,
F.
Girolamo,
M.
Errede,
C.
Capobianco,
D.
Robertson,
W.
Stallcup,
R.
Perris,
L.
Roncali
(2007)
An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis
Angiogenesis, 10
-
Ain
Ayob,
T.
Ramasamy
(2018)
Cancer stem cells as key drivers of tumour progression
Journal of Biomedical Science, 25
-
M.
Iezzi,
E.
Quaglino,
A.
Amici,
P.
Lollini,
G.
Forni,
F.
Cavallo
(2012)
DNA vaccination against oncoantigens
Oncoimmunology, 1
-
L.
Conti,
S.
Lanzardo,
Maddalena
Arigoni,
Roberta
Antonazzo,
E.
Radaelli,
D.
Cantarella,
R.
Calogero,
F.
Cavallo
(2013)
The noninflammatory role of high mobility group box 1/toll‐like receptor 2 axis in the self‐renewal of mammary cancer stem cells
The FASEB Journal, 27
-
Z.
Kundu
(2014)
Classification, imaging, biopsy and staging of osteosarcoma
Indian Journal of Orthopaedics, 48
-
B.
Wilson,
K.
Imai,
P.
Natali,
S.
Ferrone
(1981)
Distribution and molecular characterization of a cell‐surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies
International Journal of Cancer, 28
-
P.
Loukopoulos,
W.
Robinson
(2007)
Clinicopathological relevance of tumour grading in canine osteosarcoma.
Journal of comparative pathology, 136 1
-
D.
Carrle,
S.
Bielack
(2009)
Osteosarcoma lung metastases detection and principles of multimodal therapy.
Cancer treatment and research, 152
-
H.
Brown,
K.
Schiavone,
F.
Gouin,
M.
Heymann,
D.
Heymann
(2017)
Biology of Bone Sarcomas and New Therapeutic Developments
Calcified Tissue International, 102
-
(2006)
Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution
, 106
-
D.
Lussier,
John
Johnson,
P.
Hingorani,
J.
Blattman
(2015)
Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma
Journal for Immunotherapy of Cancer, 3
-
M.
Benassi,
L.
Pazzaglia,
A.
Chiechi,
M.
Alberghini,
A.
Conti,
Sabrina
Cattaruzza,
Bruna
Wassermann,
P.
Picci,
R.
Perris
(2009)
NG2 expression predicts the metastasis formation in soft‐tissue sarcoma patients
Journal of Orthopaedic Research, 27
-
Y.
Pignochino,
G.
Grignani,
G.
Cavalloni,
M.
Motta,
Marta
Tapparo,
S.
Bruno,
A.
Bottos,
L.
Gammaitoni,
Giorgia
Migliardi,
G.
Camussi,
M.
Alberghini,
B.
Torchio,
S.
Ferrari,
F.
Bussolino,
F.
Fagioli,
P.
Picci,
M.
Aglietta
(2009)
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways
Molecular Cancer, 8
-
M.
Temponi,
A.
Gold,
S.
Ferrone
(1992)
Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
Cancer research, 52 9
-
Valeria
Rolih,
G.
Barutello,
S.
Iussich,
R.
Maria,
E.
Quaglino,
P.
Buracco,
F.
Cavallo,
F.
Riccardo
(2017)
CSPG4: a prototype oncoantigen for translational immunotherapy studies
Journal of Translational Medicine, 15
-
F.
Riccardo,
S.
Iussich,
L.
Maniscalco,
S.
Mayayo,
G.
Rosa,
Maddalena
Arigoni,
R.
Maria,
Francesca
Gattino,
S.
Lanzardo,
E.
Lardone,
M.
Martano,
E.
Morello,
Simone
Prestigio,
Alessandra
Fiore,
E.
Quaglino,
S.
Zabarino,
S.
Ferrone,
P.
Buracco,
F.
Cavallo
(2014)
CSPG4-Specific Immunity and Survival Prolongation in Dogs with Oral Malignant Melanoma Immunized with Human CSPG4 DNA
Clinical Cancer Research, 20
-
James
Thompson,
M.
Fugent
(1992)
Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osteosarcoma in dogs: 30 cases (1979-1990).
Journal of the American Veterinary Medical Association, 200 4
-
Jian
Wang,
A.
Svendsen,
J.
Kmiecik,
H.
Immervoll,
K.
Skaftnesmo,
J.
Planagumà,
R.
Reed,
R.
Bjerkvig,
H.
Miletic,
P.
Enger,
C.
Rygh,
M.
Chekenya
(2011)
Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma
PLoS ONE, 6
-
A.
Mittelman,
George
Chen,
G.
Wong,
Chang-Jie
Liu,
S.
Hirai,
S.
Ferrone
(1995)
Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research, 1 7
-
Shingo
Sato,
Yuning
Tang,
Qingxia
Wei,
M.
Hirata,
Angela
Weng,
I.
Han,
A.
Okawa,
S.
Takeda,
H.
Whetstone,
Puvindran
Nadesan,
D.
Kirsch,
J.
Wunder,
B.
Alman
(2016)
Mesenchymal Tumors Can Derive from Ng2/Cspg4-Expressing Pericytes with β-Catenin Modulating the Neoplastic Phenotype.
Cell reports, 16 4
-
M.
Wedekind,
L.
Wagner,
T.
Cripe
(2018)
Immunotherapy for osteosarcoma: Where do we go from here?
Pediatric Blood & Cancer, 65
-
S.
Taran,
R.
Taran,
N.
Malipatil
(2017)
Pediatric Osteosarcoma: An Updated Review
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology, 38
-
Zeyana
Rivera,
S.
Ferrone,
Xinhui
Wang,
S.
Jube,
Haining
Yang,
H.
Pass,
S.
Kanodia,
G.
Gaudino,
M.
Carbone
(2012)
CSPG4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma
Clinical Cancer Research, 18
-
S.
Mayayo,
Simone
Prestigio,
L.
Maniscalco,
G.
Rosa,
A.
Aricò,
R.
Maria,
F.
Cavallo,
S.
Ferrone,
P.
Buracco,
S.
Iussich
(2011)
Chondroitin sulfate proteoglycan-4: a biomarker and a potential immunotherapeutic target for canine malignant melanoma.
Veterinary journal, 190 2
-
G.
Bacci,
A.
Longhi,
M.
Versari,
M.
Mercuri,
A.
Briccoli,
P.
Picci
(2006)
Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy
Cancer, 106
-
Visit SAGE journals online journals.sagepub.com/ home/tam
-
Patrick
Messerschmitt,
Ashley
Rettew,
Robert
Brookover,
Ryan
Garcia,
P.
Getty,
E.
Greenfield
(2008)
Specific Tyrosine Kinase Inhibitors Regulate Human Osteosarcoma Cells In vitro
Clinical Orthopaedics and Related Research, 466
-
A.
Mittelman,
Z.
Chen,
Hong
Yang,
G.
Wong,
S.
Ferrone
(1992)
Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma.
Proceedings of the National Academy of Sciences of the United States of America, 89 2
-
D.
Harrison,
D.
Geller,
Jonathan
Gill,
Valerae
Lewis,
R.
Gorlick
(2018)
Current and future therapeutic approaches for osteosarcoma
Expert Review of Anticancer Therapy, 18
-
F.
Riccardo,
L.
Aurisicchio,
J.
Impellizeri,
F.
Cavallo
(2015)
The importance of comparative oncology in translational medicine
Cancer Immunology, Immunotherapy, 64
-
A.
Schmidt,
M.
Nielen,
O.
Klungel,
A.
Hoes,
A.
Boer,
R.
Groenwold,
J.
Kirpensteijn
(2013)
Prognostic factors of early metastasis and mortality in dogs with appendicular osteosarcoma after receiving surgery: an individual patient data meta-analysis.
Preventive veterinary medicine, 112 3-4
-
Jie
Xu,
Lu
Xie,
Wei
Guo
(2018)
PDGF/PDGFR effects in osteosarcoma and the “add-on” strategy
Clinical Sarcoma Research, 8
-
Xinhui
Wang,
E.
Ko,
Liaomin
Peng,
S.
Gillies,
S.
Ferrone
(2005)
Human high molecular weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: enhancement of immunogenicity of anti-idiotypic monoclonal antibody MK2-23 by fusion with interleukin 2.
Cancer research, 65 15
-
K.
Imai,
A.
Ng,
M.
Glassy,
S.
Ferrone
(1981)
Differential effect of interferon on the expression of tumor-associated antigens and histocompatibility antigens on human melanoma cells: relationship to susceptibility to immune lysis mediated by monoclonal antibodies.
Journal of immunology, 127 2
-
J.
Fenger,
C.
London,
W.
Kisseberth
(2014)
Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
ILAR journal, 55 1
-
Tracy
Marko,
B.
Diessner,
L.
Spector
(2016)
Prevalence of Metastasis at Diagnosis of Osteosarcoma: An International Comparison
Pediatric Blood & Cancer, 63
-
(2012)
DNA vaccination against oncoantigens: a promise
, 1
-
Alexander
Birbrair,
Tan
Zhang,
Zhong‐Min
Wang,
M.
Messi,
A.
Mintz,
O.
Delbono
(2013)
Type-1 pericytes participate in fibrous tissue deposition in aged skeletal muscle.
American journal of physiology. Cell physiology, 305 11
-
L.
Piras,
F.
Riccardo,
S.
Iussich,
L.
Maniscalco,
Francesca
Gattino,
M.
Martano,
E.
Morello,
S.
Mayayo,
Valeria
Rolih,
F.
Garavaglia,
R.
Maria,
E.
Lardone,
Francesco
Collivignarelli,
D.
Mignacca,
D.
Giacobino,
Soldano
Ferrone,
Federica
Cavallo,
P.
Buracco
(2017)
Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4‐antigen electrovaccination
Veterinary and Comparative Oncology, 15